key: cord-0877970-qx5wzjgg
authors: Lala, Anuradha; Januzzi, James; Pinney, Sean P.; Mancini, Donna M.; Fuster, Valentin
title: Reply: What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients?
date: 2020-12-08
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2020.10.013
sha: e8db1fc168b6b524262f964a590389f0dd77afac
doc_id: 877970
cord_uid: qx5wzjgg

nan

understanding the underlying pathophysiology of myocardial injury in the setting of COVID-19 was beyond the scope of our paper. Indeed, several months after our data were collected, the causal relationship between severe acute respiratory syndromecoronavirus-2 and cardiac involvement remains elusive and requires further study (3) . Systematic study of ECGs among affected patients is of interest. Dr. Lala has received speaker honoraria from Zoll. Dr. Januzzi is a Trustee of the American College of Cardiology; has received grant support from Novartis Pharmaceuticals and Abbott Diagnostics; has received consulting income from Abbott, Janssen, Novartis, MyoKardia, and Roche Diagnostics; and participates in clinical endpoint committees/data safety monitoring boards for Abbott, AbbVie, Amgen, CVRx, Janssen, and Takeda. Dr. Pinney has received consulting fees from Abbott, CareDx, Medtronic, and Procyrion; has participated in clinical endpoint committees for Abbott, Axon, SoniVie, and Transmedics; and has received honoraria from Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Patrick O'Gara, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.

Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection

Fourth universal definition of myocardial infarction

COVID-19 can affect the heart

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Patrick O'Gara, MD, served as Guest Associate Editor for this paper. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.